Clinical Trials Directory

Trials / Completed

CompletedNCT02933983

Microbiota Upper Respiratory Tract

Study of the Microbiota and the Potential of Probiotics for Chronic Rhinosinusitis

Status
Completed
Phase
Study type
Observational
Enrollment
325 (actual)
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (URT) (nose, nasopharynx and sinuses) of chronic rhinosinusitis (CRS) patients is disturbed compared to healthy individuals. Therefore, bacterial DNA from swabs, aspirates and tissue will be isolated via commercially available DNA extraction kits, followed by Illumina MiSeq sequencing in order to identify the bacterial species present in these samples. Special attention will go to microbial species that are overrepresented in the healthy populations as potential health promoting microbes (i.e. probiotics). A better understanding of the URT microbiome might help us to better understand the pathology of CRS and might help to develop new microbiota-based strategies for CRS.

Conditions

Interventions

TypeNameDescription
OTHERno intervention, compare URT microbiome healthy control group-chronic rhinosinusitis patients

Timeline

Start date
2015-05-01
Primary completion
2018-08-24
Completion
2018-08-24
First posted
2016-10-14
Last updated
2020-04-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02933983. Inclusion in this directory is not an endorsement.